HY-134669-100mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-25mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-5mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-134669-50mg
|
MedChemexpress LLC
|
CypK [CAS 1610703-09-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-10mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-100mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-25mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-5mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
HY-148870-50mg
|
MedChemexpress LLC
|
Maytansinoid B [CAS 1628543-40-7]
|
|
Cancer-programmed cell death
|
|
H2A228-1
|
Virusys Corporation
|
HSV-2, Chicken Polyclonal Antibody
|
Virus
|
ELISA, IF, WB
|
|